Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.jim.2004.10.012
Title: Evaluation of a safe and sensitive Spike protein-based immunofluorescence assay for the detection of antibody responses to SARS-CoV
Authors: Manopo, I.
Lu, L.
He, Q.
Chee, L.L.
Chan, S.-W. 
Kwang, J. 
Keywords: Antibody detection
IFA
SARS-CoV
Spike protein
Issue Date: 2005
Source: Manopo, I., Lu, L., He, Q., Chee, L.L., Chan, S.-W., Kwang, J. (2005). Evaluation of a safe and sensitive Spike protein-based immunofluorescence assay for the detection of antibody responses to SARS-CoV. Journal of Immunological Methods 296 (1-2) : 37-44. ScholarBank@NUS Repository. https://doi.org/10.1016/j.jim.2004.10.012
Abstract: Previously, we have identified a truncated antigenic fragment named protein C [441 to 700 amino acids (a.a.)] as the immunodominant fragment of Spike (S) protein of severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV). We have now successfully expressed protein C using the baculovirus system in S. frugiperda (Sf-9) cells. This recombinant baculovirus expressing protein C was first characterized using five SARS convalescent human sera and five normal human sera. The results showed that protein C is an authentic antigen against SARS-CoV antibody. Our Spike protein-based immunoflourescence assay (IFA) based on this recombinant baculovirus-Sf-9 system was further assessed with a panel of 163 clinical samples collected during the SARS epidemic in Singapore, which include samples from 21 clinically confirmed SARS, 42 non-SARS patient sera, and 100 normal sera. The results were compared to a commercial SARS IFA kit (EUROIMMUN, Germany) and a conventional IFA test performed in Singapore General Hospital. All of the 21 SARS-positive serum samples could be recognized by our IFA, giving a specificity and sensitivity of 100%, which was compatible with both whole virus-based IFA assays. No cross-reactivity with serum samples against infectious bronchitis virus (IBV) and transmissible gastroenteritis virus (TGEV) were detected in our assays. Thus, our Spike protein-based IFA could offer a safer procedure which can be performed in a BSL-2 laboratory as it could mimic the whole virus based-IFA without any loss of sensitivity and specificity. It is also more user-friendly and cost-effective than the whole virus-based IFA. © 2004 Elsevier B.V. All rights reserved.
Source Title: Journal of Immunological Methods
URI: http://scholarbank.nus.edu.sg/handle/10635/31506
ISSN: 00221759
DOI: 10.1016/j.jim.2004.10.012
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

10
checked on Dec 5, 2017

WEB OF SCIENCETM
Citations

10
checked on Nov 16, 2017

Page view(s)

171
checked on Dec 10, 2017

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.